Nephroprotection via SGLT2 inhibition

Wanner, C

Wanner, C (reprint author), Univ Klinikum Wurzburg, Schwerpunkt Nephrol, Med Klin & Poliklin 1, Oberdurrbacherstr 6, D-97070 Wurzburg, Germany.

DIABETOLOGE, 2018; 14 (2): 93

Abstract

Renal effects of empagliflozin and canagliflozin. In 2016 and 2017, two major outcomes studies, the EMPA-REG OUTCOME trial (EMPA-REG OUTCOME: Empaglif......

Full Text Link